<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39363389</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1099-1050</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Health economics</Title><ISOAbbreviation>Health Econ</ISOAbbreviation></Journal><ArticleTitle>Socioeconomic inequalities in waiting times for breast cancer surgery.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1002/hec.4906</ELocationID><Abstract><AbstractText>Prompt access to cancer care is a policy priority in several OECD countries, because delayed access can exacerbate deleterious health outcomes. Access to care based on need remains a key pillar of publicly-funded health systems. This study tests for the presence of inequalities in waiting times by socioeconomic status for patients receiving breast cancer surgery (mastectomy or breast conserving surgery) in England using the Hospital Episode Statistics. We investigate separately the pre-COVID-19 period (April 2015-January 2020), and the COVID-19 period (February 2020-March 2022). We use linear regression models to study the association between waiting times and income deprivation measured at the patient's area of residence. We control for demographic factors, type and number of comorbidities, past emergency admissions and Healthcare Resource Groups, and supply-level factors through hospital fixed effects. In the pre-COVID-19 period, we do not find statistically significant associations between income deprivation in the patient's area of residence and waiting times for surgery. In the COVID-19 period, we find that patients living in the most deprived areas have longer waiting times by 0.7 days (given a mean waiting time of 20.6 days).</AbstractText><CopyrightInformation>© 2024 The Author(s). Health Economics published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Matias</LastName><ForeName>Maria Ana</ForeName><Initials>MA</Initials><Identifier Source="ORCID">0000-0002-8782-3311</Identifier><AffiliationInfo><Affiliation>Centre for Health Economics, University of York, York, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Rita</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-7953-1960</Identifier><AffiliationInfo><Affiliation>Centre for Health Economics, University of York, York, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siciliani</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1739-7289</Identifier><AffiliationInfo><Affiliation>Centre for Health Economics, University of York, York, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Economics and Related Studies, University of York, York, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sivey</LastName><ForeName>Peter</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-3703-615X</Identifier><AffiliationInfo><Affiliation>Centre for Health Economics, University of York, York, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Proctor</LastName><ForeName>Andrew</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Oncology, York and Scarborough Teaching Hospitals NHS Foundation Trust, York, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PR-PRU-1217-20301</GrantID><Agency>National Institute for Health and Care Research</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Health Econ</MedlineTA><NlmUniqueID>9306780</NlmUniqueID><ISSNLinking>1057-9230</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">access</Keyword><Keyword MajorTopicYN="N">breast cancer</Keyword><Keyword MajorTopicYN="N">inequalities</Keyword><Keyword MajorTopicYN="N">waiting times</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>9</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>0</Hour><Minute>12</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39363389</ArticleId><ArticleId IdType="doi">10.1002/hec.4906</ArticleId></ArticleIdList><ReferenceList><Title>REFERENCES</Title><Reference><Citation>Aarts, M. J., Hamelinck, V. C., Bastiaannet, E., Coebergh, J. W. W., Liefers, G. J., Voogd, A. C., van der Sangen, M., &amp; Louwman, W. J. (2012). Small but significant socioeconomic inequalities in axillary staging and treatment of breast cancer in The Netherlands. British Journal of Cancer, 107(1), 12–17. https://doi.org/10.1038/bjc.2012.205</Citation></Reference><Reference><Citation>Bhola, J., Jain, A., &amp; Foden, P. (2015). Impact of index of multiple deprivation and ethnicity on breast screening uptake in the North West of England. Breast Cancer Research, 17(S1), 1–13. https://doi.org/10.1186/bcr3786</Citation></Reference><Reference><Citation>Booth, C. M., Li, G., &amp; Mackillop, W. J. (2009). The impact of socioeconomic status (SES) on stage of cancer at time of diagnosis: A population‐based study in Ontario, Canada. Journal of Clinical Oncology, 27(15), 6505. https://doi.org/10.1200/jco.2009.27.15_suppl.6505</Citation></Reference><Reference><Citation>Bosque‐Mercader, L., Carrilero, N., García‐Altés, A., López‐Casasnovas, G., &amp; Siciliani, L. (2023). Socioeconomic inequalities in waiting times for planned and cancer surgery: Evidence from Spain. Health Economics, 32(5), 1181–1201. https://doi.org/10.1002/hec.4661</Citation></Reference><Reference><Citation>Brindley, C., Lomas, J., &amp; Siciliani, L. (2023). The effect of hospital spending on waiting times. Health Economics, 32(11), 2427–2445. https://doi.org/10.1002/hec.4735</Citation></Reference><Reference><Citation>Burn, S., Propper, C., Stoye, G., Warner, M., Aylin, P., &amp; Bottle, A. (2021). What happened to English NHS hospital activity during the Covid‐19 pandemic? IFS Briefing Note, BN328.</Citation></Reference><Reference><Citation>Cancer Research UK. (2023). Breast cancer statistics. Retrieved from https://crukcancerintelligence.shinyapps.io/EarlyDiagnosis/</Citation></Reference><Reference><Citation>Clover, B. Long cancer waits at highest rate since pandemic hit. 2022 https://www.hsj.co.uk/quality‐and‐performance/long‐cancer‐waits‐at‐highest‐rate‐since‐pandemic‐hit/7032307</Citation></Reference><Reference><Citation>Cookson, R., Gutacker, N., Garcia‐Armesto, S., Angulo‐Pueyo, E., Christiansen, T., Bloor, K., &amp; Bernal‐Delgado, E. (2015). Socioeconomic inequality in hip replacement in four European countries from 2002 to 2009—Area‐level analysis of hospital data. The European Journal of Public Health, 25(1), 21–27. https://doi.org/10.1093/eurpub/cku220</Citation></Reference><Reference><Citation>Corner, J., &amp; Brindle, L. (2011). The influence of social processes on the timing of cancer diagnosis: A research agenda. Journal of Epidemiology &amp; Community Health, 65(6), 477–482. https://doi.org/10.1136/jech.2008.084285</Citation></Reference><Reference><Citation>Dasgupta, P., Baade, P. D., Aitken, J. F., &amp; Turrell, G. (2012). Multilevel determinants of breast cancer survival: Association with geographic remoteness and area‐level socioeconomic disadvantage. Breast Cancer Research and Treatment, 132(2), 701–710. https://doi.org/10.1007/s10549‐011‐1899‐y</Citation></Reference><Reference><Citation>Department of Health. (2000). The NHS cancer plan. Department of Health.</Citation></Reference><Reference><Citation>Downing, A., Prakash, K., Gilthorpe, M. S., Mikeljevic, J. S., &amp; Forman, D. (2007). Socioeconomic background in relation to stage at diagnosis, treatment and survival in women with breast cancer. British Journal of Cancer, 96(5), 836–840. https://doi.org/10.1038/sj.bjc.6603622</Citation></Reference><Reference><Citation>Duffy, S. W., Seedat, F., Kearins, O., Press, M., Walton, J., Myles, J., Vulkan, D., Sharma, N., &amp; Mackie, A. (2022). The projected impact of the COVID‐19 lockdown on breast cancer deaths in England due to the cessation of population screening: A national estimation. British Journal of Cancer, 126(9), 1355–1361. https://doi.org/10.1038/s41416‐022‐01714‐9</Citation></Reference><Reference><Citation>Figueroa, J. D., Gray, E., Pashayan, N., Deandrea, S., Karch, A., Vale, D. B., Elder, K., Procopio, P., van Ravesteyn, N. T., Mutabi, M., Canfell, K., &amp; Nickson, C., &amp; &amp; Breast Screening Working Group. (2021). The impact of the Covid‐19 pandemic on breast cancer early detection and screening. Preventive Medicine, 151, 106585. https://doi.org/10.1016/j.ypmed.2021.106585</Citation></Reference><Reference><Citation>Forrest, L. F., Adams, J., Wareham, H., Rubin, G., &amp; White, M. (2013). Socioeconomic inequalities in lung cancer treatment: Systematic review and meta‐analysis. PLoS Medicine, 10(2), e1001376. https://doi.org/10.1371/journal.pmed.1001376</Citation></Reference><Reference><Citation>Fraser, C., &amp; Fisher, R. (2021). How has the COVID‐19 pandemic impacted primary care? https://www.health.org.uk/news‐and‐comment/charts‐and‐infographics/how‐has‐the‐covid‐19‐pandemic‐impacted‐primary‐care</Citation></Reference><Reference><Citation>GOV.UK. (2019). National statistics: English indices of deprivation 2019. Retrieved from https://www.gov.uk/government/statistics/english‐indices‐of‐deprivation‐2019</Citation></Reference><Reference><Citation>GOV.UK. (2023). Guidance: Breast screening: Programme overview. Retrieved from https://www.gov.uk/guidance/breast‐screening‐programme‐overview</Citation></Reference><Reference><Citation>Gu, J., Groot, G., Boden, C., Busch, A., Holtslander, L., &amp; Lim, H. (2018). Review of factors influencing women's choice of mastectomy versus breast conserving therapy in early stage breast cancer: A systematic review. Clinical Breast Cancer, 18(4), e539–e554. https://doi.org/10.1016/j.clbc.2017.12.013</Citation></Reference><Reference><Citation>Hanna, T. P., King, W. D., Thibodeau, S., Jalink, M., Paulin, G. A., Harvey‐Jones, E., O’Sullivan, D. E., Booth, C. M., Sullivan, R., &amp; Aggarwal, A. (2020). Mortality due to cancer treatment delay: Systematic review and meta‐analysis. BMJ, 371, m4087. https://doi.org/10.1136/bmj.m4087</Citation></Reference><Reference><Citation>Johar, M., Jones, G., Keane, M. P., Savage, E., &amp; Stavrunova, O. (2013). Discrimination in a universal health system: Explaining socioeconomic waiting time gaps. Journal of Health Economics, 32(1), 181–194. https://doi.org/10.1016/j.jhealeco.2012.09.004</Citation></Reference><Reference><Citation>Kaarboe, O. M., &amp; Carlsen, F. (2014). Waiting times and socioeconomic status. Evidence from Norway. Health Economics, 23(1), 93–107. https://doi.org/10.1002/hec.2904</Citation></Reference><Reference><Citation>Kasteridis, P., Siciliani, L., &amp; Sivey, P. (2023). Waiting time prioritisation in the health sector: Evidence from hip replacement surgery. Centre for Health Economics, Alcuin College, University of York. Retrieved from https://www.york.ac.uk/media/che/CHE%20RP%20194%20FINAL.pdf</Citation></Reference><Reference><Citation>Kurani, S. S., McCoy, R. G., Lampman, M. A., Doubeni, C. A., Rutten, L. J. F., Inselman, J. W., Giblon, R. E., Bunkers, K. S., Stroebel, R. J., Rushlow, D., Chawla, S. S., &amp; Shah, N. D. (2020). Association of neighborhood measures of social determinants of health with breast, cervical, and colorectal cancer screening rates in the US Midwest. JAMA Network Open, 3(3), e200618. https://doi.org/10.1001/jamanetworkopen.2020.0618</Citation></Reference><Reference><Citation>Landi, S., Ivaldi, E., &amp; Testi, A. (2018). Socioeconomic status and waiting times for health services: An international literature review and evidence from the Italian National Health System. Health Policy, 122(4), 334–351. https://doi.org/10.1016/j.healthpol.2018.01.003</Citation></Reference><Reference><Citation>Laudicella, M., Siciliani, L., &amp; Cookson, R. (2012). Waiting times and socioeconomic status: Evidence from England. Social Science &amp; Medicine, 74(9), 1331–1341. https://doi.org/10.1016/j.socscimed.2011.12.049</Citation></Reference><Reference><Citation>Marmot, M. G., Altman, D. G., Cameron, D. A., Dewar, J. A., Thompson, S. G., &amp; Wilcox, M. (2013). The benefits and harms of breast cancer screening: An independent review. British Journal of Cancer, 108(11), 2205–2240. https://doi.org/10.1038/bjc.2013.177</Citation></Reference><Reference><Citation>Monstad, K., Engesaeter, L. B., &amp; Espehaug, B. (2014). Waiting time and socioeconomic status ‐ an individual‐level analysis. Health Economics, 23(4), 446–461. https://doi.org/10.1002/hec.2924</Citation></Reference><Reference><Citation>Morrissey, K., Spooner, F., Salter, J., &amp; Shaddick, G. (2021). Area level deprivation and monthly COVID‐19 cases: The impact of government policy in England. Social Science &amp; Medicine, 289, 114413. https://doi.org/10.1016/j.socscimed.2021.114413</Citation></Reference><Reference><Citation>Moscelli, G., Siciliani, L., Gutacker, N., &amp; Cookson, R. (2018). Socioeconomic inequality of access to healthcare: Does choice explain the gradient? Journal of Health Economics, 57, 290–314. https://doi.org/10.1016/j.jhealeco.2017.06.005</Citation></Reference><Reference><Citation>Moscelli, G., Siciliani, L., Gutacker, N., &amp; Gravelle, H. (2016). Location, quality and choice of hospital: Evidence from England 2002–2013. Regional Science and Urban Economics, 60, 112–124. https://doi.org/10.1016/j.regsciurbeco.2016.07.001</Citation></Reference><Reference><Citation>Mottram, R., Knerr, W. L., Gallacher, D., Fraser, H., Al‐Khudairy, L., Ayorinde, A., Williamson, S., Nduka, C., Uthman, O. A., Johnson, S., Tsertsvadze, A., Stinton, C., Taylor‐Phillips, S., &amp; Clarke, A. (2021). Factors associated with attendance at screening for breast cancer: A systematic review and meta‐analysis. BMJ Open, 11(11), e046660. https://doi.org/10.1136/bmjopen‐2020‐046660</Citation></Reference><Reference><Citation>National Cancer Registration and Analysis Service. (2024). Cancer data by stage at diagnosis. Retrieved from https://www.cancerdata.nhs.uk/stage_at_diagnosis</Citation></Reference><Reference><Citation>National Institute for Health and Care Excellence. (2021). Suspected cancer: Recognition and referral. Recommendations organised by site of cancer. Retrieved from https://www.nice.org.uk/guidance/ng12/chapter/Recommendations‐organised‐by‐site‐of‐cancer#breast‐cancer</Citation></Reference><Reference><Citation>NHS. (2021b). Your breast screening results. Retrieved from https://www.nhs.uk/conditions/breast‐screening‐mammogram/your‐results/</Citation></Reference><Reference><Citation>NHS England. (2016a). Clinical Guidelines for the Management of breast cancer, west Midlands Expert Advisory group for breast cancer. Retrieved from https://www.england.nhs.uk/mids‐east/wp‐content/uploads/sites/7/2018/02/guidelines‐for‐the‐management‐of‐breast‐cancer‐v1.pdf</Citation></Reference><Reference><Citation>NHS Executive. (2000). The NHS cancer plan. A plan for investment A plan for reform. Department of Health. Retrieved from https://www.thh.nhs.uk/documents/_Departments/Cancer/NHSCancerPlan.pdf</Citation></Reference><Reference><Citation>NHS Improvement. (2010). Going further on cancer waits: The symptomatic breast two Week wait standard. Retrieved from https://www.england.nhs.uk/wp‐content/uploads/2015/03/symptomatic‐breast‐standard.pdf</Citation></Reference><Reference><Citation>OECD. (2020). Waiting times for health services: Next in line, OECD health policy studies. OECD Publishing. https://doi.org/10.1787/242e3c8c‐en</Citation></Reference><Reference><Citation>Raine, R., Wong, W., Scholes, S., Ashton, C., Obichere, A., &amp; Ambler, G. (2010). Social variations in access to hospital care for patients with colorectal, breast, and lung cancer between 1999 and 2006: Retrospective analysis of hospital episode statistics. BMJ, 340, b5479. https://doi.org/10.1136/bmj.b5479</Citation></Reference><Reference><Citation>Redaniel, M. T., Martin, R. M., Cawthorn, S., Wade, J., &amp; Jeffreys, M. (2013). The association of waiting times from diagnosis to surgery with survival in women with localised breast cancer in England. British Journal of Cancer, 109(1), 42–49. https://doi.org/10.1038/bjc.2013.317</Citation></Reference><Reference><Citation>Saito, M. K., Quaresma, M., Fowler, H., Majano, S. B., &amp; Rachet, B. (2021). Exploring socioeconomic differences in surgery and in time to elective surgery for colon cancer in England: Population‐based study. Cancer Epidemiology, 71, 101896. https://doi.org/10.1016/j.canep.2021.101896</Citation></Reference><Reference><Citation>Sharma, A., Siciliani, L., &amp; Harris, A. (2013). Waiting times and socioeconomic status: Does sample selection matter? Economic Modelling, 33, 659–667. https://doi.org/10.1016/j.econmod.2013.05.009</Citation></Reference><Reference><Citation>Siciliani, L. (2016). Waiting times: Evidence of social inequalities in access for care. In B. Sobolev, A. Levy, &amp; S. Goring (Eds.), Data and measures in health services research (pp. 1–17). Health Services Research. Springer.</Citation></Reference><Reference><Citation>Simonsen, N. F., Oxholm, A. S., Kristensen, S. R., &amp; Siciliani, L. (2020). What explains differences in waiting times for health care across socioeconomic status? Health Economics, 29(12), 1764–1785. https://doi.org/10.1002/hec.4163</Citation></Reference><Reference><Citation>Smith, D., Thomson, K., Bambra, C., &amp; Todd, A. (2019). The breast cancer paradox: A systematic review of the association between area‐level deprivation and breast cancer screening uptake in Europe. Cancer Epidemiology, 60, 77–85. https://doi.org/10.1016/j.canep.2019.03.008</Citation></Reference><Reference><Citation>Stevens, S., &amp; Pritchard, A. (2020). Important and urgent ‐ Next steps on the NHS response to COVID‐19. https://www.england.nhs.uk/coronavirus/wp‐content/uploads/sites/52/2020/03/urgent‐next‐steps‐on‐nhs‐response‐to‐covid‐19‐letter‐simon‐stevens.pdf</Citation></Reference><Reference><Citation>Sun, L., Cromwell, D., Dodwell, D., Horgan, K., Gannon, M. R., Medina, J., Pennington, M., Legood, R., dos‐Santos‐Silva, I., &amp; Sadique, Z. (2020). Costs of early invasive breast cancer in England using national patient‐level data. Value in Health, 23(10), 1316–1323. https://doi.org/10.1016/j.jval.2020.05.013</Citation></Reference><Reference><Citation>Toss, A., Isca, C., Venturelli, M., Nasso, C., Ficarra, G., Bellelli, V., Tazzioli, G., Barbieri, E., Cortesi, L., Moscetti, L., Piacentini, F., Omarini, C., Andreotti, A., Gambini, A., Battista, R., &amp; Dominici, M. (2021). Two‐month stop in mammographic screening significantly impacts on breast cancer stage at diagnosis and upfront treatment in the COVID era. ESMO Open, 6(2), 100055. https://doi.org/10.1016/j.esmoop</Citation></Reference><Reference><Citation>Watt, T., Sullivan, R., &amp; Aggarwal, A. (2022). Primary care and cancer: An analysis of the impact and inequalities of the COVID‐19 pandemic on patient pathways. BMJ Open, 12(3), e059374. https://doi.org/10.1136/bmjopen‐2021‐059374</Citation></Reference><Reference><Citation>Willett, K. (2020). COVID‐19 NHS preparedness and response. Notification of return to Incident Level4. https://www.england.nhs.uk/coronavirus/documents/professor‐keith‐willett‐level‐4‐letter‐4‐november‐2020/</Citation></Reference></ReferenceList></PubmedData></PubmedArticle>